Multiple Myeloma and Plasma Cell Neoplasm Clinical Trials

295 clinical trials for Multiple Myeloma and Plasma Cell Neoplasm across international registries, including 3 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Registry of Older Patients With Cancer — RECRUITING
• 68Ga-BCMA PET/CT in Multiple Myeloma — RECRUITING · PHASE2
• Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer — RECRUITING
• 3'-Deoxy-3'-[18F] Fluorothymidine PET Imaging in Patients With Cancer — ACTIVE_NOT_RECRUITING
• Donor Peripheral Stem Cell Transplant in Treating Patients With Advanced Hematologic Cancer or Other Disorders — ACTIVE_NOT_RECRUITING · PHASE2
• Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer — COMPLETED · PHASE2
• Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma — COMPLETED · PHASE3
• Lenalidomide and Melphalan in Treating Patients With Previously Untreated Multiple Myeloma — COMPLETED · PHASE2
• High-Dose Melphalan Plus Peripheral Stem Cell Transplantation in Treating Patients With Primary Systemic Amyloidosis — COMPLETED · PHASE2
• Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma — COMPLETED · PHASE2
• Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell Transplantation — TERMINATED · PHASE1
• Biological Therapy in Treating Patients With Multiple Myeloma That Has Recurred Following Bone Marrow Transplantation — COMPLETED · PHASE2
• Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma — COMPLETED · PHASE3
• Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma — COMPLETED · PHASE1
• Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma — COMPLETED · PHASE2
• Research Study in Healthy Volunteers of Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma — COMPLETED
• Collecting and Storing Blood Samples From Patients With Cancer — WITHDRAWN
• Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases — COMPLETED · PHASE1
• Bortezomib, Thalidomide, and Dexamethasone After Melphalan and Stem Cell Transplant in Treating Patients With Stage I-III Multiple Myeloma — COMPLETED · PHASE2
• High-Dose Melphalan With or Without Radiolabeled Monoclonal Antibody in Treating Patients With Multiple Myeloma Undergoing an Autologous Stem Cell Transplant — TERMINATED · PHASE2
• Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia — COMPLETED · PHASE2
• Arsenic Trioxide in Treating Patients With Multiple Myeloma — TERMINATED · PHASE2
• Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple Myeloma — TERMINATED · PHASE2
• Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer — TERMINATED · NA
• Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant — COMPLETED · NA
• Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma — COMPLETED · PHASE1
• Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter — COMPLETED · PHASE3
• Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer — COMPLETED · PHASE3
• Ultraviolet-B Light Therapy and Allogeneic Stem Cell Transplantation in Treating Patients With Hematologic Malignancies — COMPLETED · NA
• Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial — COMPLETED · PHASE3
• Combination Chemotherapy Followed By Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer or Severe Aplastic Anemia — COMPLETED · PHASE1
• Busulfan, Cyclophosphamide, and Autologous Stem Cell Transplant in Treating Patients With Multiple Myeloma — COMPLETED · PHASE2
• Treatment for Chronic Pain in Patients With Advanced Cancer — COMPLETED · PHASE3
• Thalidomide and Prednisone Following Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma — COMPLETED · PHASE2
• Combination Chemotherapy in Treating Patients With Multiple Myeloma — COMPLETED · PHASE3
• NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders — COMPLETED · PHASE2
• Hydroxychloroquine and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma — COMPLETED · PHASE1
• Lenalidomide With or Without Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma — COMPLETED · PHASE2
• Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer — COMPLETED · PHASE1
• Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer — COMPLETED · PHASE2
• Alemtuzumab Plus Fludarabine and Melphalan With or Without Cyclosporine, Mycophenolate Mofetil, and Low-Dose Total-Body Irradiation Therapy Followed by Donor Peripheral Stem Cell Transplant in Treating Patients With Hematologic Cancer — WITHDRAWN · PHASE1
• T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant — TERMINATED
• Chemotherapy and Peripheral Stem Cell Transplantation Followed By Immunotherapy in Treating Patients With Multiple Myeloma — COMPLETED · PHASE1
• Mycophenolate Mofetil, Tacrolimus, Daclizumab, and Donor Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer — COMPLETED · PHASE2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma — COMPLETED · PHASE2
• Bone Marrow Transplantation in Treating Patients With Hematologic Cancer — COMPLETED · PHASE4
• Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer — COMPLETED · PHASE2
• Peripheral Stem Cell Transplantation Plus Combination Chemotherapy in Treating Patients With Multiple Myeloma — COMPLETED · PHASE2
• Chemotherapy Plus Donor White Blood Cell Infusion in Treating Patients With Relapsed Hematologic Cancer Following Donor Peripheral Stem Cell Transplantation — COMPLETED · PHASE1
• Oblimersen, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma — COMPLETED · PHASE2

Refine this search